지씨지놈

340450KOSDAQ그외 기타 전문, 과학 및 기술 서비스업

69.8 / 100

Reference Date: 2026-07-24

Financial Score28.5 / 40

News Sentiment21.3 / 25

Momentum10.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE significantly exceeds the industry average and the debt ratio is very low with excellent financial health is also solid. Surged 16.9% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

GC Genomics is a clinical genomics analysis company established in 2013, specializing in developing precision medicine technologies that utilize genomic big data for disease prevention and personalized treatment. Its core business includes four areas: prenatal/neonatal screening, cancer precision diagnosis, rare disease diagnosis, and health check-ups, with services provided to over 1,000 medical institutions domestically and 22 countries globally, solidifying its market position internationally.

Number of Employees

131people

Average Salary

53.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

28.22Industry Average 42.306.5Point

Lower than industry avg (good)

PBR

1.58Industry Average 1.082.5Point

Higher than industry avg (caution)

ROE

7.26Industry Average 0.947.0Point

7.7x industry avg (excellent)

Debt Ratio

4.62Industry Average 12.516.5Point

Half of industry avg (excellent)

Trend 6.0 / 10 points

Revenue Growth Rate

1.5 / 3

Operating Profit Growth Rate

1.5 / 3

ROE Trend

3.0 / 4

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Positive
지씨지놈, 축적한 데이터 성과 입증…일본과 미국 진출로 성장동력 확.....
GC지놈의 임상유전체 데이터 플랫폼과 의료 네트워크 성과가 입증되며 일본 및 미국 시장 진출로 성장 가능성이 높아졌다.

Detailed Momentum

52-week position1.0Point

Near 52w low (16%, downtrend)

Current 5,220Won52-week high 9,31052-week low 4,415

1-month return6.0Point

1m +16.91% (strong rise)

Volume trend3.0Point

Volume flat

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0